NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000001964

Registered date:14/05/2009

Ocular hypotensive effects of TAPROS ophthalmic solution 0.0015%.

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedGlaucoma
Date of first enrollment2008/12/01
Target sample size10
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)TAPROS ophthalmic solution 0.0015%

Outcome(s)

Primary OutcomeIntraocular pressure reduction, % reduction of intraocular pressure.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum16years-old
Age maximum90years-old
GenderMale and Female
Include criteria
Exclude criteria1)Presence of any external disease and inflammation of the eye. 2)History of intraocular surgery within one month. 3)Patients with Drug-induced hypersensitivity syndrome. 4)Patients with maintain over 35mmHg in intraocular pressure over one week. 5) The investigator declares any subject ineligible for any sound medical reason.

Related Information

Contact

public contact
Name
Address Nabeshima 5-1-1, Saga, Saga, 849-8501 Japan
Telephone
E-mail
Affiliation Saga University Faculty of Medicine Department of Ophthalmology
scientific contact
Name Shiniciro Ishikawa
Address Nabeshima 5-1-1, Saga, Saga, 849-8501 Japan
Telephone
E-mail
Affiliation Saga University Faculty of Medicine Department of Ophthalmology